Adjuvant analgesics for spine surgery

Area of Science:

• Anesthesiology and Pain Management
• Surgical Recovery
• Pharmacology

Background:

• Postoperative pain is often undertreated, impacting patient rehabilitation.
• Multimodal analgesia strategies are crucial but require further documentation.
• Spine surgery presents a significant challenge due to high associated pain levels.

Purpose of the Study:

• To investigate the efficacy of three adjuvant analgesics in improving multimodal pain management after spine surgery.
• To evaluate dexamethasone's effect on acute and persistent pain and opioid consumption.
• To assess chlorzoxazone and ketamine as adjuncts for acute and persistent postoperative pain.

Main Methods:

• Four studies investigated adjuvant analgesics in spine surgery patients.
• Study I & II: Preoperative intravenous dexamethasone (16 mg) vs. placebo for lumbar disk surgery.
• Study III: Oral chlorzoxazone (500 mg) vs. placebo for moderate to severe spine surgery pain.
• Study IV: Intraoperative ketamine vs. placebo for spinal fusion in opioid-dependent patients.

Main Results:

• Dexamethasone reduced acute pain during mobilization but showed no opioid-sparing effect and increased pain at 1 year.
• Chlorzoxazone demonstrated no significant effect on acute pain or opioid consumption.
• Ketamine significantly reduced postoperative opioid consumption and persistent pain at 6 months in opioid-dependent patients.

Conclusions:

• Dexamethasone and ketamine show potential as adjuvant analgesics for postoperative pain.
• Ketamine may inhibit the development of persistent postoperative pain.
• Chlorzoxazone is not effective as an adjuvant for acute pain management in this context.